SEC Form 4 · accession 0001572426-15-000080
Nexvet Biopharma plc · NVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Graeme Wald
Director
Period of report
Jul 15, 2015
Accepted (ET)
Jul 16, 2015 · 6:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jul 15, 2015 | M | 3,600 | $0.125 | A | 3,600 | D | |
| Ordinary SharesF1 | holding | — | — | — | 6,176 | I | Wald Funds Pty Ltd <Wald Funds Unit A/C> | |
| Ordinary SharesF1 | holding | — | — | — | 7,548 | I | JanCutz Pty Ltd <Emuna Superannuation Fund A/C> |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Purchase SharesF2 | $0.125 | Jul 15, 2015 | M | 3,600 | D | Sep 30, 2014 | Jul 1, 2019 | Ordinary Shares | 3,600 | 0 | D |
Explanation of responses
- F1The reporting person has sole voting and dispositive power with respect to these reported securities.
- F2The option to purchase shares vested and became exercisable as to 25% of the grant on each of 9/30/14, 12/31/14, 3/31/15 and 6/30/15.